Morgan Stanley downgraded shares of Vaccitech (NASDAQ:VACC – Free Report) from an overweight rating to an equal weight rating in a report issued on Monday, Marketbeat.com reports. They currently have $3.25 price target on the stock, down from their previous price target of $14.00. Vaccitech Stock Performance Shares of NASDAQ:VACC opened at $2.97 on Monday. […]
Health-care companies rose, as traders sought out sectors less likely to be affected by a government shutdown. Shares of Coherus BioSciences on Monday fell.
Health-care companies rose, as traders sought out sectors less likely to be affected by a government shutdown. Shares of Coherus BioSciences fell after the.
By Josh Beckerman Shares of Vaccitech more than doubled to $3.53 Monday after Alliance Global Partners discussed its prospects for blockbuster drugs. Volume.
Vaccitech plc (NASDAQ:VACC – Get Free Report) saw a significant decrease in short interest in July. As of July 15th, there was short interest totalling 8,300 shares, a decrease of 48.4% from the June 30th total of 16,100 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily […]